RPM Report

RPM Report is a premier business intelligence and strategic analysis publication focused on the pharmaceutical and biotechnology sectors, specifically addressing reimbursement, pricing, and market access. It provides in-depth coverage of regulatory developments, Medicare and Medicaid policy, and the commercial landscape for high-stakes therapeutics. The service is designed to help industry executives and stakeholders navigate the complexities of the U.S. healthcare payer environment and drug valuation. Originally part of the F-D-C Reports family, it is currently a specialized brand within the Citeline portfolio. It operates under the broader umbrella of Norstella, following the acquisition of Informa's Pharma Intelligence division by Warburg Pincus.